Vivanta Industries LtdBSE: VIVANTA

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

· Issued by Vivanta Industries Ltd via BSE India

Filed with BSE · · 2 pages · English

Summary by 6ix AI

Vivanta Industries Ltd has announced the execution of business collaboration agreements with Qness Pharmaceuticals for the manufacture, supply, branding, and marketing of pharmaceutical products. The agreements aim to enhance Vivanta's product portfolio and market reach without involving any equity participation or share exchange. No upfront consideration has been paid, and commercial terms will be determined through individual purchase orders. The arrangement does not involve related party transactions, ensuring that it is conducted at arm's length.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Vivanta Industries Limited has entered into certain business collaboration agreements with Qness Pharmaceuticals, a proprietorship concern in connection with the manufacture, supply, branding and marketing of pharmaceutical and allied products.

Vivanta Industries Ltd on 6ix

Story so far

Earlier from Vivanta Industries

Later from Vivanta Industries

All Vivanta Industries news releases